NDC 50072-010

TPOXX

Tecovirimat Monohydrate

TPOXX is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Siga Technologies, Inc.. The primary component is Tecovirimat.

• Product ID: 50072-010_70b3a765-cf50-476b-904d-0d272bcc8a72
• NDC: 50072-010
• Product Type: Human Prescription Drug
• Proprietary Name: TPOXX
• Generic Name: Tecovirimat Monohydrate
• Dosage Form: Injection, Solution, Concentrate
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2022-05-31
• Marketing Category: NDA /
• Application Number: NDA214518
• Labeler Name: SIGA Technologies, Inc.
• Substance Name: TECOVIRIMAT
• Active Ingredient Strength: 10 mg/mL
• Pharm Classes: Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 50072-010-01

7 VIAL in 1 CARTON (50072-010-01) > 20 mL in 1 VIAL (50072-010-30)

• Marketing Start Date: 2022-05-31
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "TPOXX" or generic name "Tecovirimat Monohydrate"

NDC	Brand Name	Generic Name
50072-010	TPOXX	tecovirimat monohydrate
50072-200	TPOXX	tecovirimat monohydrate